SM
CRDF icon

Sabby Management’s Cardiff Oncology CRDF Stock Holding History

Sabby Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-275
Closed -$255K – 171
2021
Q1 		$255K Sell
275
-2,347
-90% -$28.5K 0.05% 128
2020
Q4 		$4.72M Buy
2,622
+2,305
+727% +$40.5K 0.9% 21
2020
Q3 		$450K Buy
+317
New +$2.09K 0.07% 86

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management's CRDF Position: Q4 2018 in Review

Sabby Management sold out of Cardiff Oncology (CRDF) in Q4 2018, closing a stake of 25,606 shares — an estimated $125K sold.

Sabby Management first reported a position in CRDF in Q4 2013 and held it in 12 quarters. The position peaked at $1.23M in Q3 2017. 26 funds tracked by Wall St. Rank hold CRDF as of Q4 2018.

  • Sabby Management reported no remaining Cardiff Oncology position as of Q4 2018 after selling out during the quarter.
  • Sabby Management sold 25,606 Cardiff Oncology shares in Q4 2018, an estimated $125K.
  • Sabby Management first reported a position in Cardiff Oncology in Q4 2013 and held it in 12 quarters.
  • Sabby Management's Cardiff Oncology position peaked at $1.23M in Q3 2017.
  • 26 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2018.

Based on Sabby Management's 13F filing for Q4 2018, filed 14 Feb 2019.